2 Blue Chip Dividend Stocks That Are Top Buys in August
If you are looking for reliable dividend stocks that can provide steady income and growth in any market condition, you might want to consider these two blue chip companies that have proven their resilience and strength over time. Read on to find out more.
Abbott Laboratories (NYSE: ABT) is a global leader in healthcare products and services, with a diversified portfolio of medical devices, diagnostics, nutrition, and branded generic drugs. The company has a long history of innovation and excellence and has increased its dividend for 51 consecutive years.
In the second quarter of 2023, Abbott reported strong organic sales growth across three of its four operating segments, namely medical devices, established pharmaceuticals, and nutrition. During the quarter, the company benefited from the recovery in medical procedures after the pandemic-induced slowdown, the ongoing rebound in its infant formula business after last year's voluntary recall, and the robust demand for its continuous glucose monitoring franchise known as FreeStyle Libre.
Source Fool.com
Abbott Laboratories Stock
With 21 Buy predictions and not a single Sell prediction Abbott Laboratories is an absolute favorite of our community.
As a result the target price of 116 € shows a slightly positive potential of 13.9% compared to the current price of 101.84 € for Abbott Laboratories.
